Rhoen Competitors

Pink Sheets . USA . 
Stock . Rhoen Klinikum AG
RKAGY Stock  USD 7.60  0.00  0.00%   
Rhoen Klinikum AG competes with Extendicare, Life Healthcare, WashTec AG, Panamera Holdings, and Raffles Medical; as well as few others. The company classifies itself under Healthcare sector and is part of Medical Care Facilities industry. Analyzing Rhoen Klinikum competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Rhoen Klinikum to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Rhoen Klinikum Correlation with its peers.

Rhoen Klinikum vs LifeTech Scientific Correlation

Moving against Rhoen Pink Sheet

  0.69JDHIF JD Health InternationalPairCorr
  0.65VFSWW VinFast AutoPairCorr
  0.56UHS Universal Health ServicesPairCorr
  0.45FMS Fresenius Medical CarePairCorr
  0.43THC Tenet Healthcare Earnings Call This WeekPairCorr
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
7.217.607.99
Details
Intrinsic
Valuation
LowRealHigh
7.157.547.93
Details
Naive
Forecast
LowNextHigh
7.267.658.04
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
7.607.607.60
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Rhoen Klinikum. Your research has to be compared to or analyzed against Rhoen Klinikum's peers to derive any actionable benefits. When done correctly, Rhoen Klinikum's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Rhoen Klinikum AG.

Rhoen Klinikum Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Rhoen Klinikum and its competitors represents the degree of relationship between the price movements of corresponding pink sheets. A correlation of about +1.0 implies that the price of Rhoen and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Rhoen Klinikum AG does not affect the price movement of the other competitor.

High positive correlations

LFTSF
+ 1.0
NWKHY
ARRJF
+ 0.65
LTGHY
ARRJF
+ 0.51
EXETF
RAFLF
+ 0.42
WHTCF
LTGHY
+ 0.28
EXETF
WHTCF
+ 0.24
LTGHY
  

High negative correlations

ARRJF
- 0.59
PHCI
SAFLY
- 0.58
RAFLF
SAFLY
- 0.58
WHTCF
RAFLF
- 0.58
EXETF
PHCI
- 0.54
LTGHY
WHTCF
- 0.51
EXETF

Risk-Adjusted Indicators

There is a big difference between Rhoen Pink Sheet performing well and Rhoen Klinikum Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Rhoen Klinikum's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
EXETF  1.43  0.67  0.39  3.29  0.68 
(1.85)
 3.03 
(1.85)
 16.28 
NWKHY  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
LTGHY  1.91  0.17  0.06  0.39  2.00 
(2.54)
 3.98 
(3.02)
 14.60 
LTGHF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
WHTCF  1.94 (0.40) 0.00 (0.30) 0.00 
 0.00 
 4.07 
(4.27)
 18.01 
PHCI  0.93 (0.10) 0.00  0.29  0.00 
 0.00 
 1.88 
(3.09)
 17.31 
RAFLF  0.30 (0.14) 0.00  0.57  0.00 
 0.00 
 0.00 
 0.00 
 10.00 
ARRJF  0.20  0.08  0.00  0.41  0.00 
 0.00 
 0.00 
 0.00 
 2.45 
SAFLY  0.54  0.25  0.00  1.27  0.00 
 0.00 
 0.00 
 0.00 
 17.99 
LFTSF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 

Rhoen Klinikum Competitive Analysis

The better you understand Rhoen Klinikum competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Rhoen Klinikum's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Rhoen Klinikum's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
RKAGY EXETF NWKHY LTGHY WHTCF PHCI RAFLF ARRJF SAFLY LFTSF
 0.00 
 7.60 
Rhoen
 1.94 
 17.33 
Extendicare
 0.00 
 7.17 
Netcare
 0.34 
 2.93 
Life
 0.33 
 3.00 
WashTec
 2.00 
 7.35 
Panamera
 0.00 
 0.72 
Raffles
 0.00 
 3.50 
Arjo
 0.00 
 4.00 
Safilo
 0.00 
 0.23 
LifeTech
Market Volatility
(90 Days Market Risk)
Very steady
Not too volatile
Very steady
Dangerous
Relatively risky
Somewhat reliable
Very risky
Not too volatile
Slightly risky
Very steady
Market Performance
(90 Days Performance)
Fair
Solid
Weakest
Mild
Weakest
Weakest
Weakest
Solid
Fair
Weakest
Odds of Financial Distress
(Probability Of Bankruptcy)
Low
Low
Hazard
Small
Small
High
Low
Low
Low
Low
Current Valuation
(Equity Enterprise Value)
Fairly Valued
Under Valued
Over Valued
Under Valued
Fairly Valued
Over Valued
Over Valued
Fairly Valued
Under Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Hold
Strong Buy
Strong Hold
Not Rated
Cautious Hold
Strong Sell
Strong Sell
Buy
Strong Buy
Strong Sell
Current Ratio
2.31
1.09
1.01
0.61
1.14
0.13
1.07
1.37
1.82
3.81
Net Asset
1.67 B
900.32 M
26.27 B
42.24 B
1.26 B
10
1.55 B
14.61 B
937.77 M
3.18 B
Profit Margin
0.0183
0.0532
0.0468
0.0539
-0.0539
-0.82
0.14
0.0448
0.0505
0.3
EBITDA
98.83 M
79.64 M
3.56 B
3.24 B
21 M
(90.75 K)
161.27 M
2.03 B
101.96 M
397.59 M
Operating Margin
0.0187
0.12
0.1
0.0944
0.0561
-0.78
0.19
N/A
0.0621
0.37
Current Valuation
928.19 M
556.43 M
1.66 B
2.06 B
716.7 M
78.05 M
1.82 B
1.13 B
782.28 M
1.34 B
Price To Book
0.68
4.28
1.76
1.27
0.95
N/A
2.25
1.43
1.71
4.34
Five Year Return
N/A
6.6
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Asset
N/A
N/A
N/A
3.1 B
110 M
N/A
212 M
N/A
674 M
N/A
Retained Earnings
N/A
N/A
N/A
N/A
14 M
N/A
318 M
N/A
84 M
N/A
Beta
0.0421
1.2
0.26
0.31
1.39
1.47
0.61
0.22
1.38
0.77
Number Of Employees
18.15 K
31
32
45
1.51 K
3
2.7 K
6.5 K
4.46 K
1.14 K
Shares Outstanding
133.88 M
83.94 M
133.82 M
360.93 M
228.17 M
33.21 M
1.85 B
272.37 M
206.79 M
4.63 B
Cash Flow From Operations
97.5 M
63.42 M
2.61 B
4.23 B
22.27 M
(99.36 K)
160.11 M
1.73 B
17.3 M
488.85 M
Annual Yield
0.0147
0.0721
0.0553
0.0244
N/A
N/A
0.0153
0.0212
0.18
N/A
Total Debt
148.56 M
463.27 M
5.26 B
10.33 B
290.6 M
28.95 K
77.91 M
118 M
131.8 M
10.19 M
Return On Equity
0.0265
0.0018
0.0975
0.0878
-0.0104
N/A
0.11
0.0616
0.16
0.11
Z Score
4.2
1.0
N/A
N/A
1.2
N/A
14.4
5.4
4.0
92.4
Return On Asset
0.0114
0.11
0.0539
0.0404
0.0149
-3.23
0.0624
0.0335
0.0412
0.073
Book Value Per Share
8.58
1.49
76.56
51.94
3.09
-0.001
0.51
2.23
1.93
0.56
Current Liabilities
N/A
N/A
N/A
4.59 B
108 M
N/A
180 M
N/A
378 M
N/A
Total Asset
1.67 B
900.32 M
26.27 B
42.24 B
1.26 B
10
1.55 B
14.61 B
937.77 M
3.18 B
Debt To Equity
0.13
2.85
1.02
0.65
0.48
N/A
0.18
0.94
0.53
0.003
Last Dividend Paid
N/A
0.48
0.5
0.4
N/A
N/A
0.018
N/A
N/A
N/A
Shares Owned By Institutions
N/A
17.61
N/A
N/A
5.16
N/A
15.91
48.15
N/A
20.78
Market Capitalization
1.09 B
419.69 M
1.23 B
1.36 B
650.75 M
20.76 M
1.92 B
1.07 B
662.67 M
1.57 B
Price To Earning
540.83
500.0
43.42
18.63
17.43
N/A
31.4
71.78
48.33
30.91
Price To Sales
0.66
0.32
0.0528
0.0477
0.89
4587.48
2.49
1.13
0.64
1.54
Net Income
28.3 M
11.5 M
1.01 B
1.53 B
(43.79 M)
(95.35 K)
84.17 M
742 M
21.27 M
292.47 M
Earnings Per Share
0.23
0.01
0.4
0.23
-0.17
-0.003
0.04
0.19
0.15
0.01
Shares Owned By Insiders
N/A
13.15
N/A
N/A
9.72
87.98
55.3
20.91
N/A
17.06
Revenue
1.4 B
1.22 B
21.64 B
28.21 B
302.32 M
41.67 K
723.79 M
9.07 B
969.58 M
925.33 M
Working Capital
N/A
N/A
N/A
(1.49 B)
2 M
N/A
32 M
N/A
296 M
N/A
Cash And Equivalents
367.94 M
174.61 M
1.39 B
1.15 B
57.12 M
4.18 K
289.07 M
70.15 M
99 M
1.41 B
Cash Per Share
2.8
2.08
10.4
3.16
0.25
N/A
0.16
0.26
0.48
0.3
Gross Profit
182.63 M
283.88 M
10.55 B
8.36 B
153.69 M
3.45 K
193.55 M
4.21 B
512.62 M
747.53 M
Day Typical Price
7.6
17.29
7.17
2.93
3.0
7.35
0.72
3.5
4.0
0.23
Accumulation Distribution
N/A
22.5
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Daily Balance Of Power
0.0
2.538462
0.0
0
0
0
0.0
0.0
0.0
0.0
Period Momentum Indicator
N/A
0.33
N/A
(0.01)
(0.01)
(0.15)
N/A
N/A
N/A
N/A
Rate Of Daily Change
1.0
1.02
1.0
1.0
1.0
0.98
1.0
1.0
1.0
1.0
Day Median Price
7.6
17.27
7.17
2.93
3.0
7.35
0.72
3.5
4.0
0.23
Price Action Indicator
N/A
0.23
N/A
(0.01)
(0.01)
(0.07)
N/A
N/A
N/A
N/A
Relative Strength Index
100.0
73.9
N/A
57.6
44.81
31.92
N/A
100.0
100.0
N/A
Coefficient Of Variation
812.4
321.44
N/A
1248.49
(925.07)
(2,006)
(812.40)
455.94
812.4
N/A
Mean Deviation
0.0931
1.43
N/A
1.91
1.94
0.9275
0.2984
0.2048
0.537
N/A
Jensen Alpha
0.0413
0.6732
N/A
0.1678
(0.40)
(0.1)
(0.14)
0.0818
0.2492
N/A
Total Risk Alpha
0.0034
0.4891
N/A
(0.03)
(0.59)
(0.33)
(0.27)
0.0542
0.0672
N/A
Sortino Ratio
N/A
0.3901
N/A
0.0601
N/A
N/A
N/A
N/A
N/A
N/A
Downside Variance
N/A
2.54
N/A
5.11
N/A
N/A
N/A
N/A
N/A
N/A
Standard Deviation
0.3841
2.24
N/A
2.63
2.94
2.29
1.23
0.4898
2.21
N/A
Kurtosis
66.0
13.66
N/A
3.88
3.62
12.48
66.0
18.38
66.0
N/A
Potential Upside
N/A
3.03
N/A
3.98
4.07
1.88
N/A
N/A
N/A
N/A
Treynor Ratio
(0.60)
3.29
N/A
0.3946
(0.30)
0.2852
0.5659
0.4051
1.27
N/A
Maximum Drawdown
3.12
16.28
N/A
14.6
18.01
17.31
10.0
2.45
17.99
N/A
Variance
0.1476
5.02
N/A
6.93
8.67
5.25
1.52
0.2399
4.91
N/A
Market Risk Adjusted Performance
(0.59)
3.3
N/A
0.4046
(0.29)
0.2952
0.5759
0.4151
1.28
N/A
Risk Adjusted Performance
0.0814
0.2355
N/A
0.0661
(0.07)
(0.03)
(0.09)
0.1563
0.0972
N/A
Skewness
8.12
2.62
N/A
0.7854
0.5315
0.3709
(8.12)
4.44
8.12
N/A
Semi Deviation
N/A
0.6839
N/A
2.0
N/A
N/A
N/A
N/A
N/A
N/A
Information Ratio
(0.07)
0.2777
N/A
0.0516
(0.13)
(0.08)
(0.18)
0.0664
0.0893
N/A
Value At Risk
N/A
(1.85)
N/A
(3.02)
(4.27)
(3.09)
N/A
N/A
N/A
N/A
Expected Short fall
N/A
(1.85)
N/A
(2.54)
N/A
N/A
N/A
N/A
N/A
N/A
Downside Deviation
N/A
1.59
N/A
2.26
N/A
N/A
N/A
N/A
N/A
N/A
Semi Variance
N/A
0.4677
N/A
4.02
N/A
N/A
N/A
N/A
N/A
N/A

Rhoen Klinikum Competition Performance Charts

Five steps to successful analysis of Rhoen Klinikum Competition

Rhoen Klinikum's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Rhoen Klinikum AG in relation to its competition. Rhoen Klinikum's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Rhoen Klinikum in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Rhoen Klinikum's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Rhoen Klinikum AG, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Rhoen Klinikum position

In addition to having Rhoen Klinikum in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Blockchain Thematic Idea Now

Blockchain
Blockchain Theme
Companies across muliple sectors and different technology products and services that are engaged in some capacity with blockchain technolgoy or evolution of cryptocurrency. The Blockchain theme has 28 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Blockchain Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Rhoen Pink Sheet Analysis

When running Rhoen Klinikum's price analysis, check to measure Rhoen Klinikum's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rhoen Klinikum is operating at the current time. Most of Rhoen Klinikum's value examination focuses on studying past and present price action to predict the probability of Rhoen Klinikum's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rhoen Klinikum's price. Additionally, you may evaluate how the addition of Rhoen Klinikum to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY